Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

LIDAMITOL™ solution for IM injection 100mg/ml+2.5mg/ml (1ml), ampoules 5pcs

🔥 3 items sold in last 3 hours
11 people are viewing this product
Brand:
Active Ingredient:

,

Manufacturer:

$33.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

LIDAMITOL™ solution for IV and IM injection 100mg/ml+2.5mg/ml (1ml), 10pcs

$38.00
Add to cart

Analogs of LIDAMITOL™

AKRIOL™ PRO topical cream 2.5%+2.5% (100g), 1pc

$168.00
Add to cart

AKRIOL™ PRO topical cream 2.5%+2.5% (30g), 1pc

$78.00
Add to cart

AKRIOL™ PRO topical cream 2.5%+2.5% (5g), 1pc

$18.00
Add to cart

AMBENIUM™ PARENTERAL solution for i.m. injection 373.4mg/2ml+3.75mg/2ml (2ml), 3pcs

$115.00
Add to cart

Table of Contents

LIDAMITOL™ 100mg+2.5mg Solution 1ml 5pcs Buy Online

Lidamitol Solution for IM Injection: A Comprehensive Overview

Managing muscle spasms and spasticity can be challenging, impacting daily life significantly. Lidamitol, a solution for intramuscular injection, offers a potential avenue for relief. This comprehensive overview explores its applications, mechanisms, and considerations.

Understanding Lidamitol

Lidamitol is a prescription medication available as a solution for intramuscular (IM) injection. Its primary function is to alleviate muscle spasms and spasticity, conditions that can significantly impact mobility and quality of life. The formulation combines two active components working synergistically to achieve this therapeutic effect. This dual-action approach targets both the central and peripheral nervous systems, offering a comprehensive approach to muscle relaxation.

Tolperisone hydrochloride, a major component, acts as a central muscle relaxant. It works by reducing the overactivity of neurons in the spinal cord that contribute to muscle stiffness and spasms. This action helps to diminish the signals that cause involuntary muscle contractions. The precise mechanism of action is complex and involves interactions with various neurotransmitter systems in the central nervous system.

In addition to tolperisone, Lidamitol includes a second active ingredient, lidocaine, a local anesthetic. Lidocaine’s role is to provide local pain relief at the injection site, minimizing discomfort during administration. This added benefit enhances patient comfort and compliance with the prescribed treatment regimen. The combined action of these two components contributes to the overall efficacy of Lidamitol in managing muscle-related issues.

Understanding the specific roles of each component in Lidamitol is crucial for appreciating its therapeutic potential. The combination of central muscle relaxation and local anesthetic action distinguishes it from other muscle relaxants. This unique combination makes it a valuable tool for healthcare professionals in managing a range of musculoskeletal conditions. Further research continues to unravel the intricacies of its mechanism of action, leading to a more precise understanding of its therapeutic effects.

Mechanism of Action

Lidamitol’s effectiveness stems from the combined actions of its two key components: tolperisone hydrochloride and lidocaine. Tolperisone, a central muscle relaxant, primarily targets the central nervous system (CNS). It modulates neuronal activity within the spinal cord, thereby reducing the transmission of signals that cause muscle spasms and hypertonia. This results in a decrease in muscle stiffness and involuntary contractions, improving overall motor function.

The precise mechanism by which tolperisone achieves this effect is multifaceted and not fully elucidated. However, it’s believed to involve interactions with various neurotransmitter systems, including those related to gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the CNS. By influencing GABAergic pathways, tolperisone helps to dampen excessive neuronal excitability, thereby promoting muscle relaxation.

Lidocaine, a local anesthetic, plays a crucial secondary role. It acts primarily at the injection site, providing local analgesia. By reducing pain and discomfort associated with the injection itself, lidocaine enhances patient compliance and overall treatment experience. This targeted pain relief is a key advantage, improving patient comfort and reducing potential anxiety around injections.

The synergistic effect of these two active components distinguishes Lidamitol. The combination of central muscle relaxation and local anesthetic action makes it a unique and effective treatment option for various musculoskeletal conditions. While the precise interactions between tolperisone and lidocaine aren’t fully understood, their combined action contributes significantly to Lidamitol’s therapeutic benefits, improving patient outcomes and reducing the burden of muscle-related disorders.

Therapeutic Applications

Lidamitol’s therapeutic applications primarily focus on the management of muscle spasticity and pain associated with various musculoskeletal conditions. Its dual mechanism of action—central muscle relaxation and local analgesia—makes it a valuable treatment option for a range of patients experiencing these debilitating symptoms. The targeted relief provided by Lidamitol can significantly improve mobility and quality of life.

One significant application is in the management of spasticity following a stroke. Stroke-related spasticity can severely limit mobility and functional independence. Lidamitol’s ability to relax spastic muscles can help patients regain some degree of movement and perform daily activities more easily. This improvement in motor function can significantly enhance their overall well-being and participation in social activities.

Beyond stroke rehabilitation, Lidamitol finds use in treating painful muscle spasms associated with various conditions. These conditions can include degenerative spinal disorders like spondylosis and spondyloarthrosis, as well as cervical and lumbar syndromes. By reducing muscle spasms and providing local pain relief, Lidamitol can alleviate pain and discomfort, enhancing comfort and improving daily function for patients suffering from these conditions.

The versatility of Lidamitol extends to other applications. It can be beneficial in managing myofascial pain syndrome, a chronic condition characterized by widespread muscle pain and tenderness. The reduction of muscle tension and pain provided by Lidamitol can offer significant relief to those struggling with this often debilitating condition. The efficacy of Lidamitol in these diverse applications underscores its importance as a therapeutic option in the management of various musculoskeletal disorders.

Administration and Dosage

The administration of Lidamitol is exclusively via intramuscular (IM) injection. This route of administration ensures efficient absorption of the active components into the bloodstream, leading to prompt therapeutic effects. Healthcare professionals should strictly adhere to prescribed dosage guidelines and injection techniques to ensure safe and effective administration.

Dosage regimens vary depending on the individual patient’s condition, response to treatment, and overall health status. A healthcare provider will determine the appropriate dosage based on a thorough assessment of the patient’s needs. It is crucial to follow the prescribed dosage carefully, avoiding any self-adjustment of the medication. Improper dosage can compromise efficacy and potentially lead to adverse effects.

Typically, the recommended dosage involves administering a specific volume of Lidamitol solution through IM injection. The frequency of injections also depends on the individual’s response and the severity of their condition. Regular monitoring by a healthcare professional is essential to evaluate the effectiveness of the treatment and to make any necessary adjustments to the dosage or treatment plan. This close monitoring helps to optimize treatment outcomes and minimize potential risks.

It’s vital to emphasize that Lidamitol should only be administered by trained medical professionals. Improper injection techniques can lead to complications such as local tissue damage, hematoma formation, or nerve injury. Patients should never attempt self-administration. Always consult with a physician or other qualified healthcare provider for guidance on proper administration and dosage of Lidamitol. Their expertise ensures safe and effective treatment.

Potential Side Effects

While Lidamitol generally offers significant therapeutic benefits, it’s crucial to be aware of potential side effects. These side effects, although generally mild and transient, warrant attention. Patients should promptly report any unusual symptoms to their healthcare provider for appropriate management. Early intervention can often minimize discomfort and prevent complications.

Some commonly reported side effects include local reactions at the injection site. These reactions might manifest as mild pain, redness, swelling, or itching. These are usually temporary and resolve spontaneously within a short period. However, if these symptoms persist or worsen, medical attention should be sought. Careful monitoring of the injection site is recommended.

Systemic side effects, while less common, can also occur. These may include drowsiness, dizziness, or nausea. Such effects are usually mild and subside as the body adjusts to the medication. However, patients experiencing excessive drowsiness or dizziness should avoid activities requiring alertness, such as driving or operating machinery. Adjustments to dosage or alternative treatments might be considered in such cases.

In rare instances, more serious side effects may arise. These are uncommon but necessitate immediate medical attention. Examples include allergic reactions, characterized by symptoms like hives, rash, or difficulty breathing. Such severe reactions demand prompt medical intervention. Healthcare providers should be thoroughly informed about any history of allergies before initiating Lidamitol therapy to mitigate these risks. Patient safety is paramount.

Pros

Lidamitol offers several key advantages in managing muscle spasticity and associated pain. Its dual mechanism of action, combining central muscle relaxation and local analgesia, provides a comprehensive approach to symptom relief. This dual action often leads to a more significant improvement in patient comfort and functionality compared to single-action medications.

The inclusion of lidocaine as a local anesthetic is a significant advantage. This component minimizes pain and discomfort during injection, enhancing patient compliance with the treatment regimen. Improved patient experience contributes to better adherence and ultimately, more effective management of the underlying condition. Patient comfort is a crucial aspect of successful therapy.

Many patients experience a noticeable improvement in their ability to perform daily activities. The reduction in muscle spasticity and pain allows for increased mobility and participation in social and occupational activities. This enhanced quality of life is a substantial benefit, restoring independence and improving overall well-being. Enhanced functional capacity is a major goal of treatment.

Compared to some other muscle relaxants, Lidamitol often demonstrates a favorable side effect profile. While side effects can occur, they are typically mild and transient. This makes it a potentially well-tolerated option for many patients. Careful monitoring and communication with a healthcare provider remain essential to manage any potential adverse effects effectively. The overall balance between benefits and risks needs to be considered on an individual basis.

Cons

While Lidamitol offers significant therapeutic benefits, potential drawbacks need consideration. The requirement for intramuscular injection might be a deterrent for some patients who prefer oral medications or other less invasive delivery methods. The injection itself can cause discomfort, although lidocaine aims to minimize this. Patient preference and tolerance for injections should be factored into treatment decisions.

Although generally well-tolerated, Lidamitol can cause side effects. While many are mild and transient, such as local injection site reactions or mild drowsiness, the possibility of adverse events necessitates careful monitoring. Patients should be aware of potential side effects and promptly report any concerning symptoms to their healthcare provider. Close monitoring can help mitigate potential problems and ensure patient safety.

The need for prescription and medical supervision represents another potential limitation. Lidamitol is not an over-the-counter medication and requires a physician’s assessment to determine suitability and dosage. Regular follow-up appointments for monitoring treatment response and adjusting the dosage as needed are essential components of successful therapy. This level of medical oversight increases the complexity of treatment for some patients.

Furthermore, individual responses to Lidamitol can vary significantly. While it proves effective for many, some patients may experience insufficient relief of symptoms despite adhering to the prescribed regimen. In such cases, alternative treatment options may need to be explored. Treatment plans should be individualized and adjusted based on the patient’s specific response and overall health status. A collaborative approach between patient and physician is crucial for optimal management.

Storage and Handling

Proper storage and handling of Lidamitol are crucial to maintain its potency and ensure patient safety. Incorrect storage can degrade the medication, rendering it ineffective or even potentially harmful. Adherence to recommended storage guidelines is non-negotiable for optimal therapeutic outcomes. Always follow the instructions provided by your pharmacist or healthcare provider.

Lidamitol should be stored at a controlled temperature, typically below a specified threshold to prevent degradation of the active ingredients. Exposure to extreme temperatures, either hot or cold, can compromise the medication’s stability and effectiveness. Always check the product labeling for the precise temperature requirements and ensure the storage location meets these specifications. Consistent temperature control is essential.

Protection from light and moisture is also vital. Exposure to direct sunlight or excessive humidity can accelerate the degradation process. Therefore, Lidamitol should be stored in a cool, dark, and dry place, ideally away from direct sunlight. Keeping the medication in its original container, tightly closed, provides an added layer of protection against environmental factors. Proper packaging helps maintain product integrity.

Handling of Lidamitol ampoules requires care to avoid accidental breakage and potential exposure to the solution. Always handle ampoules with caution, avoiding excessive pressure or rough handling. Dispose of used ampoules appropriately, following the instructions provided by your healthcare provider or local waste disposal guidelines. Safe disposal prevents environmental contamination and ensures patient safety. Careful handling throughout the process minimizes risk.

Conclusion

Lidamitol solution for IM injection presents a valuable therapeutic option for managing muscle spasticity and associated pain. Its unique combination of tolperisone hydrochloride and lidocaine offers a dual mechanism of action, targeting both central and peripheral aspects of muscle dysfunction. This multifaceted approach contributes to its effectiveness in alleviating symptoms and improving patient quality of life.

While generally well-tolerated, the potential for side effects necessitates careful monitoring and adherence to prescribed dosage regimens. The need for intramuscular administration and medical supervision should be considered. However, the potential benefits in terms of improved mobility, reduced pain, and enhanced functional capacity often outweigh the potential risks for many patients.

The efficacy of Lidamitol in treating various conditions, including stroke-related spasticity and myofascial pain syndrome, underscores its importance in the management of musculoskeletal disorders. Its ability to improve both motor function and pain relief contributes significantly to improving patient outcomes. However, individual responses to treatment vary, highlighting the importance of individualized care and close collaboration between patients and their healthcare providers.

Ultimately, the decision to use Lidamitol should be made in consultation with a healthcare professional. A thorough assessment of the patient’s condition, medical history, and potential risks is essential to determine the suitability of Lidamitol and to develop a tailored treatment plan. This collaborative approach ensures that patients receive the most appropriate and effective care for their specific needs, maximizing the benefits and minimizing potential drawbacks.

  • Lidamitol™ Solution For Im Injection 100Mg/Ml+2.5Mg/Ml (1Ml), Ampoules 5Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Lidamitol™ Solution For Im Injection 100Mg/Ml+2.5Mg/Ml (1Ml), Ampoules 5Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Lidamitol™ Solution For Im Injection 100Mg/Ml+2.5Mg/Ml (1Ml), Ampoules 5Pcs Buy Online 6
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “LIDAMITOL™ solution for IM injection 100mg/ml+2.5mg/ml (1ml), ampoules 5pcs”

Your email address will not be published. Required fields are marked

Similar products

MILGAMMA™ COMPOSITUM tablets 100mg+100mg, 30pcs

$56.00
Add to cart

MIDOCALM-RICHTER™ solution for intramuscular injection 100mg+2.5mg/ml (1ml), 5pcs

$41.00
Add to cart

METADOXIL™ tablets 500mg, 10pcs

$68.00
Add to cart

LIPOIC ACID tablets 25mg, 50pcs

$7.00
Add to cart

LARIGAMA™ solution for IM injection 2ml, 5pcs

$19.00
Add to cart

COMBILIPEN™ solution for i.m. injection 2ml, ampoules 10pcs

$25.00
Add to cart

COMBILIPEN™ solution for i.m. injection 2ml, ampoules 5pcs

$19.00
Add to cart

COMBILIPEN™ TABS tablets, 60pcs

$39.00
Add to cart

COCARNIT™ lyophilisate for IV/IM solution 187.125mg+2ml solvent, 3pcs

$59.00
Add to cart

COGITUM™ oral solution 25mg/ml (10ml), ampoules 30pcs

$226.00
Add to cart

IPIGRIX™ solution for intramuscular and subcutaneous injection 15mg/ml (1ml), 10pcs

$216.00
Add to cart

IPIGRIX™ solution for intramuscular and subcutaneous injection 5mg/ml (1ml), 10 ampoules

$141.00
Add to cart

IPIGRIX™ tablets 20mg, 100pcs

$241.00
Add to cart

IPIDACRINE VELFARM™ solution for intramuscular and subcutaneous injection 5mg/ml (1ml), 10pcs

$48.00
Add to cart

DIVAZA™ orodispersible tablets, 100pcs

$40.00
Add to cart

GOPANTAM™ tablets 500mg, 50pcs

$35.00
Add to cart

GLYCINE sublingual tablets 100mg, 50pcs

$5.00
Add to cart

GALANTAMINE CANON™ tablets 12mg, 56pcs

$222.00
Add to cart

GALANTAMINE CANON™ tablets 8mg, 56pcs

$180.00
Add to cart

HALOPERIDOL tablets 1.5mg, 50pcs

$6.00
Add to cart

BACLOSAN™ tablets 25mg, 50pcs

$33.00
Add to cart

BACLOSAN™ tablets 10mg, 50pcs

$20.00
Add to cart

AXAMON™ solution for i.m. and s.c. injection 15mg/ml (1ml), 10pcs

$143.00
Add to cart

AXAMON™ solution for i.m. and s.c. injection 5mg/ml (1ml), 10pcs

$86.00
Add to cart
Select your currency